Location History:
- Baroda, IN (2015 - 2018)
- Vadodara, IN (2022)
Company Filing History:
Years Active: 2015-2022
Title: **Sabbirhusen Yusufbhai Chimanwala: Innovator in Pharmaceutical Research**
Introduction
Sabbirhusen Yusufbhai Chimanwala is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceutical research, holding a total of three patents that focus on innovative therapeutic solutions.
Latest Patents
One of Chimanwala's latest patents involves "Malic enzyme inhibitors," which details novel compounds designed to inhibit malic enzyme (ME). This invention addresses the therapeutic treatment of disorders mediated by ME, including various types of cancer such as pancreatic ductal adenocarcinoma (PDAC). The patent presents compounds with a specific structural formula, extending the possibilities for effective cancer treatments.
Another noteworthy patent pertains to "Amidoheteroaryl aroyl hydrazide ethynes." This invention outlines compounds that function as tyrosine kinase inhibitors. It includes the processes for preparing these compounds and emphasizes their potential use in pharmaceutical compositions aimed at treating disorders related to tyrosine kinases in humans.
Career Highlights
Sabbirhusen Yusufbhai Chimanwala is currently employed with Sun Pharma Advanced Research Company Limited. His work contributes to advancing pharmaceutical sciences, particularly in the development of innovative treatments for critical health issues.
Collaborations
During his career, Chimanwala has collaborated with several professionals in the field. Notably, he has worked alongside colleagues such as Prabal Sengupta and Hemant Ashvinbhai Chokshi, contributing to a collaborative environment that fosters innovation and research excellence.
Conclusion
Sabbirhusen Yusufbhai Chimanwala's inventive contributions to pharmaceutical research exemplify the essence of innovation in healthcare. Through his patents, he continues to pave the way for new therapeutic approaches, aiming to improve patient outcomes and advance medical science. His commitment to research and collaboration is a testament to his role as a significant contributor in the field.